Calocurb triples revenue, raises $27m as it rides the GLP-1 boom
Kennedy also revealed to the Herald that her young firm’s revenue tripled from $5m to $15m last year,…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
New Zealand’s Wegovy and Ozempic alternative Calocurb says it’ll double its business with new US deal
The CRI approached supplement industry veteran Sarah Kennedy, who in 2021 formed Calocurb to commercialise the product. Kennedy’s…